Akero Therapeutics, Inc.
Overview
Akero Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing treatments for serious metabolic diseases with high unmet medical needs. The company focuses on advancing its pipeline of innovative therapies designed to treat nonalcoholic steatohepatitis (NASH) and potentially other metabolic diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Akero Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Akero Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.